Anticoagulant Reversal
1:04:13
Oct. 2024 PEP Talk: Anticoagulation and Reversal Agents
1:00:57
Update on Andexanet Alfa for Reversal of FXa Inhibitors: Annexa-I Trial Webinar
37:41
DOACs in Renal Dysfunction and Liver Disease
1:05:44
WSA Webinar - Management of stroke in the new era of oral anticoagulation
20:59
The Blessing and Curse of Direct Oral Anticoagulants in the Bleeding Patient
3:10:39
Antiplatelet, Anticoagulant, Thrombolytic Agents
25:12
Deborah Siegal, MD, MSc, FRCPC presents Updates in Anticoagulation Reversal
6:06